Two,years ago, Pfizer reached a deal that generic Lipitor, the best-selling drug in the U.S., would launch on Nov. 11, 2010 — a little more than a month from now.
- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (1)
But will it? Sanford C. Bernstein analysts Tim Anderson and Ronny Gal are out this morning with a note to investors suggesting that generic Lipitor could be delayed because of manufacturing problems at Ranbaxy, the first generic drug maker to file with the Food and Drug Administration and the company with whom Pfizer settled.
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.



